Asunción, IP Agency.- The Ministry of Public Health and Social Welfare received more than 70,000 units of medicines that will contribute to the fight against the covid-19 pandemic. The lot delivered is a courtesy from the Republic of India to Paraguay.
Through a virtual meeting, the Minister of Health, Julio Mazzoleni, thanked this support in times of the new coronavirus pandemic and highlighted the importance of interacting to share experiences and mutual knowledge.
“Cooperation, ties of friendship, especially when they occur at a time when we are all suffering, express the greatest sense of solidarity,” he emphasized.
He took advantage of the opportunity to express the commitment, effort and predisposition to learn from his own and others’ experiences, whether good or bad, in order to share knowledge and strengthen the ties of friendship between both sister nations.
Present at the virtual meeting were the ambassador of the Republic of India in Buenos Aires, Dinesh Bhatia; the Honorary Consul of the Republic of India in Paraguay, Rodolfo Javier Zucolillo; ambassador of the Republic of Paraguay in Argentina, Julio César Vera; the director of International Cooperation of the National Chancellery, Minister Cynthia Filatriga; Benito Bordón, representative of the honorary consulate of the Republic of India in Paraguay; and Nery Rodríguez, General Director of Management of Strategic Health Supplies of the MSP.
The batch of medications received consists of:
14,000 Cefotaxime sodium 1000 mg.
14.000 Ceftriaxona 1 mg Inj.
20.000 Hidroxicloroquina 200 mg Tab.
14.000 Paracetamol Intravenoso 100 ml.
14.000 Metronidazol 100 ml.
#India #delivers #medicines #support #Paraguayan #public #health
Breaking News: India’s COVID-19 Vaccination Efforts Get a Boost
As I read through the recent news articles, I was struck by the significant strides India has been making in its fight against the COVID-19 pandemic. The country has been at the forefront of COVID-19 vaccination efforts, and the latest developments are nothing short of impressive.
WashU’s Nasal COVID-19 Vaccine Approved for Emergency Use in India
According to a recent article from Washington University in St. Louis, a nasal COVID-19 vaccine based on technology licensed from the university has been approved for emergency use in India as a booster shot [[1]]. This breakthrough is a testament to the country’s commitment to staying ahead of the pandemic. The fact that a nasal vaccine has been approved for emergency use is a significant step forward, as it offers a more convenient and less invasive alternative to traditional vaccines.
COVAXIN: India’s Indigenous COVID-19 Vaccine
Another notable development in India’s COVID-19 vaccination efforts is the success of COVAXIN, the country’s first indigenous COVID-19 vaccine [[2]]. Developed by Bharat Biotech, COVAXIN has demonstrated an impressive 77.8% vaccine efficacy against symptomatic COVID-19 disease, making it a vital tool in the fight against the pandemic.
India’s Vaccination Program: A Multifaceted Approach
India’s vaccination program is a multifaceted approach that includes the use of several vaccines, including Covishield, developed by Oxford University and AstraZeneca, and manufactured by the Serum Institute of India [[3]]. This diversified approach has enabled the country to vaccinate a large portion of its population, making it a shining example of a successful vaccination program.
Conclusion
India’s COVID-19 vaccination efforts are a testament to the country’s commitment to public health and its ability to stay ahead of the pandemic. With the approval of WashU’s nasal COVID-19 vaccine and the success of COVAXIN, India is well on its way to controlling the spread of the virus. As the world continues to navigate the pandemic, India’s example serves as a reminder of the importance of innovative vaccine development and comprehensive vaccination programs.
References:
[1] https://medicine.washu.edu/news/washus-nasal-covid-19-vaccine-approved-for-use-as-booster-in-india/
[2] https://www.bharatbiotech.com/covaxin.html
[3] https://www.statista.com/statistics/1248301/india-covid-19-vaccines-administered-by-vaccine-type/
